Ftse Mib
35.410,13
0,12%
DAX
18.738,81
-0,72%
S&P 500
5.297,10
-0,21%
NASDAQ
16.698,32
-0,26%
Bitcoin
65.412,89
0,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Bayer Ord (BYR) Bayer Ord (BYR) Notizie

BYR

Bayer Ord (BYR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:BYR
DataOraFonteTitoloSimboloCompagnia
14/05/202411:15Alliance NewsAlliance NewsTOP NEWS: Bayer performs "as expected" with quarterly sales declineLSE:BYRBayer Ord
05/03/202413:17Alliance NewsAlliance NewsUPDATE: Bayer denies split-up as "not now" while swings to annual lossLSE:BYRBayer Ord
05/03/202411:13Alliance NewsAlliance NewsTOP NEWS: Bayer swings to annual loss on falling sales as costs riseLSE:BYRBayer Ord
04/03/202410:35Alliance NewsAlliance NewsBayer acquires European marketing rights to acoramidis heart treatmentLSE:BYRBayer Ord
19/02/202419:17Alliance NewsAlliance NewsTOP NEWS: Bayer slashes dividend in commitment to cutting down debtLSE:BYRBayer Ord
13/02/202418:07Alliance NewsAlliance NewsIN BRIEF: Bayer notes first patient in GenePHIT trialLSE:BYRBayer Ord
18/01/202407:09Alliance NewsAlliance NewsChemical firm Bayer confirms 'significant' workforce cuts in GermanyLSE:BYRBayer Ord
11/01/202415:29Alliance NewsAlliance NewsCORRECT: RTW Biotech's manager invests USD127 million in Ji XingLSE:BYRBayer Ord
08/01/202419:12Alliance NewsAlliance NewsBayer reports progress on two fronts for menopausal drug, elinzanetantLSE:BYRBayer Ord
08/01/202413:27Alliance NewsAlliance NewsRTW Biotech Opportunities invests USD127 million in investee Ji XingLSE:BYRBayer Ord
19/12/202306:52Alliance NewsAlliance NewsBayer's Monsanto to pay USD857 million over chemicals in schoolLSE:BYRBayer Ord
20/11/202311:51Alliance NewsAlliance NewsTOP NEWS: Bayer stock plunges on study blow for blood thinnerLSE:BYRBayer Ord
08/11/202309:40Alliance NewsAlliance NewsTOP NEWS: Bayer considers splitting up as quarterly loss balloonsLSE:BYRBayer Ord
01/11/202313:41Alliance NewsAlliance NewsBayer loses third consecutive US damages trial over Roundup weedkillerLSE:BYRBayer Ord
08/08/202309:03Alliance NewsAlliance NewsTOP NEWS: Bayer loss widens to nearly EUR2 billion on glyphosate hitLSE:BYRBayer Ord
24/07/202321:26Alliance NewsAlliance NewsTOP NEWS: Bayer cuts guidance on lower prices of glyphosate productsLSE:BYRBayer Ord
05/06/202312:39Alliance NewsAlliance NewsIN BRIEF: Bayer partners with Acquitas on lipid nanoparticle techLSE:BYRBayer Ord
11/05/202313:21Alliance NewsAlliance NewsTOP NEWS: Bayer shares fall as sales suffer on lower pricingLSE:BYRBayer Ord
28/02/202312:09Alliance NewsAlliance NewsBayer sees strong performance over 2022 but cautious over inflationLSE:BYRBayer Ord
10/02/202311:54Alliance NewsAlliance NewsIN BRIEF: Bayer's Kerendia granted label update by European CommissionLSE:BYRBayer Ord
08/02/202320:13Alliance NewsAlliance NewsTOP NEWS: Bayer appoints Bill Anderson as new chief executiveLSE:BYRBayer Ord
23/01/202312:02Alliance NewsAlliance NewsBayer's Ultravist wins contrast-enhanced mammography approval in EULSE:BYRBayer Ord
10/11/202212:10Alliance NewsAlliance NewsBayer buys German biotechnology start-up TargenomixLSE:BYRBayer Ord
09/09/202207:40Alliance NewsAlliance NewsRegeneron shares surge on positive Eylea trial dataLSE:BYRBayer Ord
12/08/202213:02Alliance NewsAlliance NewsTribunal rules against BASF in seed businesses dispute with BayerLSE:BYRBayer Ord
04/08/202209:48Alliance NewsAlliance NewsTOP NEWS: Legal woes hit Bayer's profit in second quarterLSE:BYRBayer Ord
21/06/202222:53Alliance NewsAlliance NewsUS high court denies Bayer bid to block Roundup weedkiller lawsuitsLSE:BYRBayer Ord
10/05/202209:00Alliance NewsAlliance NewsTOP NEWS: Bayer makes good start to 2022 with strong quarterly salesLSE:BYRBayer Ord
22/04/202213:16Alliance NewsAlliance NewsIN BRIEF: Bayer seeks further approval for darolutamide in ChinaLSE:BYRBayer Ord
04/04/202220:09Alliance NewsAlliance NewsIN BRIEF: Bayer notes positive new data for finerenoneLSE:BYRBayer Ord
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:BYR

La tua Cronologia

LSE
0MYD
Kupele Trencianske Tepli...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network